Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSA Real Time Price USDRecent trades of KNSA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by KNSA's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Oncostatin m receptor antigen binding proteins Oct. 22, 2024
-
Patent Title: Stable anti-osmr antibody formulation Oct. 12, 2021
-
Patent Title: Stable anti-osmr antibody formulation Dec. 03, 2019
-
Patent Title: Oncostatin m receptor antigen binding proteins Sep. 24, 2019
-
Patent Title: Stable anti-osmr antibody formulation Aug. 27, 2019
-
Patent Title: Oncostatin m receptor antigen binding proteins Aug. 22, 2017
-
Patent Title: Oncostatin m receptor antigen binding proteins May. 30, 2017
-
Patent Title: Oncostatin m receptor antigen binding proteins Mar. 14, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of KNSA in WallStreetBets Daily Discussion
Recent insights relating to KNSA
Recent picks made for KNSA stock on CNBC
ETFs with the largest estimated holdings in KNSA
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view KNSA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.